>
Americans Are Officially Out Of Money To Spend -- We Had To React
Arizona reports several cyclosporiasis cases: What to know | FOX 10 Phoenix
South Korea's AI Bubble Just Popped
It's Not Just a New Jersey Scandal – SIX States Were Previously Caught Including THOUSANDS...
Anthropic is launching its own drug discovery programs for rare diseases using Claude...
SpaceX AI Satellites Will Have 250 Kilowatts of Power
Chinese researchers have developed a sodium-metal battery that can fully charge in just 4 minutes...
SpaceX Starship Flight 13 in 3 Days - Thursday July 13
Chinese Scientists Develop Nuclear Battery Using Carbon-14
Teleoperated humanoid robots complete first-ever live surgery
Floating capsule auto-disinfects water without chemicals or battery
Modular Reactors To Solve Data Center Hysteria?
DeepSeek Developing In-House AI Chip In Bid To Cut Nvidia Reliance
America just took three brand-new nuclear reactors critical in thirty days, a first for any...

A groundbreaking study published in the Journal of Biomolecular Structure and Dynamics suggests just that — revealing how a natural compound found in licorice root might be a powerful weapon against breast cancer.
The sweet science behind glycyrrhizin
Glycyrrhizin, the active ingredient in licorice root responsible for its sweetness, has been used for centuries in traditional medicine to treat everything from sore throats to digestive issues. But now, researchers are uncovering its potential as a natural cancer-fighting agent. (Related: Licorice contains powerful cancer-killing phytochemicals.)
Using advanced computer modeling and bioinformatics — a subdiscipline of biology and computer science that uses software tools to analyze and interpret biological data — Iranian researchers mapped out exactly how this compound interacts with breast cancer cells, and the results are promising.
The study dug deep into the molecular pathways glycyrrhizin takes to combat cancer. Specifically, it focused on the breast cancer genes glycyrrhizin targets and how the compound interacts with the genes' protein products.
Of the 10 breast cancer-related genes the researchers looked at, they found that glycyrrhizin showed the highest binding affinity to three genes, namely, POLK, TBXAS1 and ADRA1A. These genes are active in three types of breast cancer: breast carcinoma, malignant neoplasm of the breast and triple-negative breast neoplasms.
The researchers reported that the protein products of these genes "had an association with [breast cancer] at several stages of tumor growth." By binding to and influencing the activities of these targets, glycyrrhizin is able to influence and control breast cancer growth and survival efficiently.
Molecular dynamics simulation also revealed that of the three interactions mapped out by the study, the destructive pathways triggered by glycyrrhizin's binding to ADRA1A had the highest likelihood of occurring.